Company / FCF Margin
INTERPACE BIOSCIENCES, INC. FCF Margin History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
14.1%
FY2025
5-year range
-141.1% / 14.1%
FY2021-FY2025
Trend
+76.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin has increased for 3 consecutive years, from -141.1% in FY2022 to 14.1% in FY2025.
Based on SEC 10-K filings.
14.1% in FY2025 with a 5-year CAGR of +62.2%.
Improved from 6.6% to 14.1% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- +155.3pp
- 5-Year Change
- +62.2pp
- 10-Year Change
- -
Key checks
Key Insights
- INTERPACE BIOSCIENCES, INC.'s fcf margin has grown for 3 consecutive years.
- In FY2025, fcf margin increased 76.1% year-over-year.
- Lowest fcf margin in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -2.84 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 14.1% | +76.1% |
| FY2024 | 8.0% | +21.5% |
| FY2023 | 6.6% | +104.7% |
| FY2022 | -141.1% | -27.5% |
| FY2021 | -110.7% | -130.6% |
| FY2020 | -48.0% | +39.1% |
| FY2019 | -78.8% | -89.2% |
| FY2018 | -41.7% | +56.7% |
| FY2017 | -96.2% | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026